Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   537,854    

Indirect Shares

   247,533      
Direct Value   $43,021,652    

Indirect Value

   $21,938,850      
Total Shares   785,387      
Total Value   $64,960,502      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,495 Incyte Corp $889,298 Immunome Inc. $103,945
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    851         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 32 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-09 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-09 4 AS $94.22 $2,847,973 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-10 4 AS $94.65 $2,845,397 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-10 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-11 4 AS $94.55 $2,840,226 D/D (30,000) 426,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-11 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-13 4 D $84.50 $2,615,444 D/D (30,952) 265,491 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-05-12 4 A $0.00 $0 D/D 32,000 45,440 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-15 4 A $0.00 $0 D/D 34,780 335,338 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-08 4 A $0.00 $0 D/D 34,780 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-03 4 A $0.00 $0 D/D 35,580 296,413 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-10 4 S $20.20 $724,917 D/D (35,886) 6,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-10 4 OE $6.46 $231,824 D/D 35,886 42,581 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-05-12 4 A $0.00 $0 D/D 36,000 86,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-12 4 A $0.00 $0 D/D 36,000 123,593 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-15 4 A $0.00 $0 D/D 36,100 523,956 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-02 4 AS $85.01 $3,102,931 D/D (36,500) 395,635 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-02 4 OE $12.99 $474,135 D/D 36,500 432,135 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 A $0.00 $0 D/D 37,800 125,901 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-15 4 D $78.27 $2,998,211 D/D (38,306) 340,543 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-03 4 A $0.00 $0 D/D 39,600 254,757 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-12 4 D $93.93 $3,755,415 D/D (39,981) 432,732 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-15 4 A $0.00 $0 D/D 40,280 378,849 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-15 4 A $0.00 $0 D/D 41,350 337,002 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-06-16 4 AS $80.55 $3,356,196 D/D (41,666) 378,584 0 -
  851  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32  33   34   35      
  Page 32 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us